+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Glucagon-Like Peptide 1 Market Report 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication, Geography, Leading Developers and Sales Forecast - Product Thumbnail Image

GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication, Geography, Leading Developers and Sales Forecast

  • Report
  • August 2024
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast

  • Report
  • May 2024
  • 16 Pages
  • Global
From
Endocrinology Drugs Market by Therapy Area (Adrenal Disorders, Diabetes, Growth Disorders), Drug Class (Calcitonin Peptides, Growth Hormone, Insulin), Mode of Administration, Patient Age Group, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Endocrinology Drugs Market by Therapy Area (Adrenal Disorders, Diabetes, Growth Disorders), Drug Class (Calcitonin Peptides, Growth Hormone, Insulin), Mode of Administration, Patient Age Group, Distribution Channel - Global Forecast 2025-2030

  • Report
  • March 2025
  • 189 Pages
  • Global
From
Diabetes Drugs Market by Product, Application, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Diabetes Drugs Market by Product, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 197 Pages
  • Global
From
Antidiabetic Drugs Market by Type, Disease, Patient - Global Forecast 2025-2030 - Product Thumbnail Image

Antidiabetic Drugs Market by Type, Disease, Patient - Global Forecast 2025-2030

  • Report
  • October 2024
  • 184 Pages
  • Global
From
Type 2 Diabetes Drugs Market by Drug, Application, Distribution - Global Forecast 2025-2030 - Product Thumbnail Image

Type 2 Diabetes Drugs Market by Drug, Application, Distribution - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Diabetes Drug Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Thumbnail Image

Diabetes Drug Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Insulin Market Size, Share & Trends Analysis Report By Product, By Application, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Insulin Market Size, Share & Trends Analysis Report By Product, By Application, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • December 2024
  • 100 Pages
  • Global
From
Pediatric Diabetes Therapeutic Market Size, Share and Trends Analysis Report by Type (Type 1, Type 2), Treatment (Insulin, GLP-1, Biguanide, SGLT2), Route of Administration, Distribution Channel, and Region 2024-2030 - Product Thumbnail Image

Pediatric Diabetes Therapeutic Market Size, Share and Trends Analysis Report by Type (Type 1, Type 2), Treatment (Insulin, GLP-1, Biguanide, SGLT2), Route of Administration, Distribution Channel, and Region 2024-2030

  • Report
  • September 2024
  • 110 Pages
  • Global
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • June 2024
  • 100 Pages
  • Global
From
GLP-1 Agonists Weight Loss Drugs Market Size, Share & Trends Analysis by Drugs (Semaglutide (Wegovy), Tirzepatide (Zepbound)), Route of Administration, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

GLP-1 Agonists Weight Loss Drugs Market Size, Share & Trends Analysis by Drugs (Semaglutide (Wegovy), Tirzepatide (Zepbound)), Route of Administration, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 153 Pages
  • Global
From
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028 - Product Thumbnail Image

Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028

  • Report
  • June 2024
  • Global
From
Semaglutides Market Report 2024 - Product Thumbnail Image

Semaglutides Market Report 2024

  • Report
  • November 2024
  • 175 Pages
  • Global
From
Liraglutide Market Report 2024 - Product Thumbnail Image

Liraglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Liraglutide and Semaglutide Market Report 2024 - Product Thumbnail Image

Liraglutide and Semaglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Antidiabetics Market Report 2024 - Product Thumbnail Image

Antidiabetics Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Non-Insulin Therapies For Diabetes Global Market Report 2024 - Product Thumbnail Image

Non-Insulin Therapies For Diabetes Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Non-Insulin Diabetes Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Non-Insulin Diabetes Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 192 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more